Chiome Bioscience Inc. (TYO:4583)

Chiome Bioscience Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	7,430	7,280	17,565	7,044	8,619	7,860
Market Cap Growth	-56.99%	-58.55%	149.35%	-18.27%	9.67%	6.96%
Enterprise Value	6,312	6,354	16,627	6,019	7,215	5,987
Last Close Price	107.00	107.00	269.00	135.00	178.00	195.00
PS Ratio	12.52	12.27	22.50	10.32	13.66	11.02
PB Ratio	6.62	6.49	9.15	6.09	4.81	4.15
P/TBV Ratio	6.62	6.49	9.15	6.09	4.81	4.15
EV/Sales Ratio	10.64	10.71	21.29	8.82	11.44	8.40
Debt / Equity Ratio	0.08	0.08	0.15	0.25	0.10	0.10
Net Debt / Equity Ratio	-1.00	-1.00	-0.93	-0.89	-0.86	-0.85
Net Debt / EBITDA Ratio	1.15	1.15	1.73	0.86	1.23	1.21
Net Debt / FCF Ratio	1.15	1.15	1.78	0.97	1.30	1.42
Asset Turnover	0.28	0.28	0.37	0.34	0.28	0.24
Inventory Turnover	4.97	4.97	6.31	4.19	4.32	3.92
Quick Ratio	3.49	3.49	4.33	2.66	5.05	4.72
Current Ratio	4.13	4.13	4.74	3.02	5.65	5.65
Return on Equity (ROE)	-64.61%	-64.61%	-66.33%	-82.76%	-67.48%	-59.16%
Return on Assets (ROA)	-29.18%	-29.18%	-30.53%	-37.97%	-34.54%	-28.59%
Return on Capital Employed (ROCE)	-72.40%	-72.40%	-52.20%	-99.40%	-68.20%	-68.50%
Earnings Yield	-13.23%	-13.50%	-5.81%	-17.32%	-14.42%	-18.83%
FCF Yield	-13.14%	-13.41%	-5.70%	-15.18%	-13.82%	-14.39%
Buyback Yield / Dilution	-16.65%	-16.65%	-17.48%	-12.64%	-9.20%	-12.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.